Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Frau

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Frontiers in Immunology|July 30, 2024
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccinationValeria Orrù, Valentina Serra, Michele Marongiu, et al.
Ebiomedicine|September 26, 2021
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapiesMaria Pia Sormani, Matilde Inglese, Irene Schiavetti, et al.
Neurology|November 3, 2017
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter studyAlice Laroni, Alessio Signori, Giorgia T Maniscalco, et al.
Ebiomedicine|May 8, 2022
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in ItalyMaria Pia Sormani, Irene Schiavetti, Matilde Inglese, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 7, 2015
The burden of multiple sclerosis variants in continental Italians and SardiniansNadia Barizzone, Ilenia Zara, Melissa Sorosina, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2018
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life studyFrancesco Saccà, Roberta Lanzillo, Alessio Signori, et al.
Multiple Sclerosis and Related Disorders|March 26, 2020
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian studyGiorgia T Maniscalco, Francesco Saccà, Roberta Lanzillo, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 18, 2020
Cladribine vs other drugs in MS: Merging randomized trial with real-life dataAlessio Signori, Francesco Saccà, Roberta Lanzillo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 2, 2019
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experienceChiara Zecca, Francesca Bovis, Giovanni Novi, et al.
Journal of Neurology|April 3, 2024
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosisElisabetta Maida, Marcello Moccia, Raffaele Palladino, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|July 30, 2024
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccinationValeria Orrù, Valentina Serra, Michele Marongiu, et al.
Ebiomedicine|September 26, 2021
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapiesMaria Pia Sormani, Matilde Inglese, Irene Schiavetti, et al.
Neurology|November 3, 2017
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter studyAlice Laroni, Alessio Signori, Giorgia T Maniscalco, et al.
Ebiomedicine|May 8, 2022
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in ItalyMaria Pia Sormani, Irene Schiavetti, Matilde Inglese, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 7, 2015
The burden of multiple sclerosis variants in continental Italians and SardiniansNadia Barizzone, Ilenia Zara, Melissa Sorosina, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2018
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life studyFrancesco Saccà, Roberta Lanzillo, Alessio Signori, et al.
Multiple Sclerosis and Related Disorders|March 26, 2020
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian studyGiorgia T Maniscalco, Francesco Saccà, Roberta Lanzillo, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 18, 2020
Cladribine vs other drugs in MS: Merging randomized trial with real-life dataAlessio Signori, Francesco Saccà, Roberta Lanzillo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 2, 2019
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experienceChiara Zecca, Francesca Bovis, Giovanni Novi, et al.
Journal of Neurology|April 3, 2024
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosisElisabetta Maida, Marcello Moccia, Raffaele Palladino, et al.
Pageof 11